# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-21-097111
Filing Date
2021-07-29
Accepted
2021-07-28 19:30:52
Documents
33
Period of Report
2021-07-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2123410d1_8k.htm iXBRL | 8-K | 29999
2 | EXHIBIT 99.1 | tm2123410d1_ex99-1.htm | EX-99.1 | 18595
6 | GRAPHIC | tm21123410d1_ex99-1image001.jpg | GRAPHIC | 205227
7 | GRAPHIC | tm21123410d1_ex99-1image002.jpg | GRAPHIC | 337749
8 | GRAPHIC | tm21123410d1_ex99-1image003.jpg | GRAPHIC | 135828
9 | GRAPHIC | tm21123410d1_ex99-1image004.jpg | GRAPHIC | 147183
10 | GRAPHIC | tm21123410d1_ex99-1image005.jpg | GRAPHIC | 144323
11 | GRAPHIC | tm21123410d1_ex99-1image006.jpg | GRAPHIC | 243099
12 | GRAPHIC | tm21123410d1_ex99-1image007.jpg | GRAPHIC | 113544
13 | GRAPHIC | tm21123410d1_ex99-1image008.jpg | GRAPHIC | 81121
14 | GRAPHIC | tm21123410d1_ex99-1image009.jpg | GRAPHIC | 78273
15 | GRAPHIC | tm21123410d1_ex99-1image010.jpg | GRAPHIC | 177130
16 | GRAPHIC | tm21123410d1_ex99-1image011.jpg | GRAPHIC | 102721
17 | GRAPHIC | tm21123410d1_ex99-1image012.jpg | GRAPHIC | 86607
18 | GRAPHIC | tm21123410d1_ex99-1image013.jpg | GRAPHIC | 264694
19 | GRAPHIC | tm21123410d1_ex99-1image014.jpg | GRAPHIC | 148644
20 | GRAPHIC | tm21123410d1_ex99-1image015.jpg | GRAPHIC | 89877
21 | GRAPHIC | tm21123410d1_ex99-1image016.jpg | GRAPHIC | 147039
22 | GRAPHIC | tm21123410d1_ex99-1image017.jpg | GRAPHIC | 97709
23 | GRAPHIC | tm21123410d1_ex99-1image018.jpg | GRAPHIC | 178513
24 | GRAPHIC | tm21123410d1_ex99-1image019.jpg | GRAPHIC | 168504
25 | GRAPHIC | tm21123410d1_ex99-1image020.jpg | GRAPHIC | 199694
| Complete submission text file | 0001104659-21-097111.txt |  | 4567286

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | anvs-20210728.xsd | EX-101.SCH | 3030
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | anvs-20210728_lab.xml | EX-101.LAB | 34239
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | anvs-20210728_pre.xml | EX-101.PRE | 22362
26 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2123410d1_8k_htm.xml | XML | 3709

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 211124266
SIC: 2834 Pharmaceutical Preparations